FFCP PHASE1:Hg19::chr2:44502711..44502719,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport= | |||
|DPIdataset=robust | |||
|EntrezGene=6519 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=11025 | |||
|TSSclassifier=strong | |||
|UniProt=G3V1I5 | |||
|association_with_transcript=93bp_to_ENST00000540334_5end | |||
|coexpression_cluster_id=C51 | |||
|description=CAGE_peak_4_at_SLC3A1_5end | |||
|id=chr2:44502711..44502719,+ | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_development_v019=UBERON:0003918;2.22e-27;10!UBERON:0007687;2.22e-27;10!UBERON:0003104;6.09e-10;31 | |||
|ontology_enrichment_disease=DOID:3493!2.27e-10!2;DOID:4929!3.58e-10!2 | |||
|ontology_enrichment_disease_v019= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002108!2.34e-11!14 | |||
|ontology_enrichment_uberon_v019=UBERON:0002113;3.86e-12;24!UBERON:0011143;3.86e-12;24!UBERON:0000489;3.03e-10;29!UBERON:0006554;6.09e-10;30!UBERON:0001008;6.09e-10;30 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0002113,2.77e-11,26;UBERON:0003918,2.77e-11,26;UBERON:0011143,2.77e-11,26;UBERON:0005095,2.77e-11,26;UBERON:0007687,2.77e-11,26;UBERON:0000489,1.20e-09,31;UBERON:0006554,1.00e-06,47 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.368277635987565,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.392937226493138,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.688992370603241,0,0,0,0,0,0,0,0,0,0,2.67939404817274,1.15400093896996,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.28120759293973,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.431855182437243,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.487671699929078,0,0,0,0,0,0,0,0,0,0,0.154348316215889,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.5290268405154,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0898252021065869,0,0,0,0,0,0 | |||
|short_description=p4@SLC3A1 | |||
}} |
Revision as of 02:52, 21 January 2014
Short description: | p4@SLC3A1 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_4_at_SLC3A1_5end |
Coexpression cluster: | C51_kidney_mesothelioma_renal_signet_gall_lung_pancreas |
Association with transcript: | 93bp_to_ENST00000540334_5end |
EntrezGene: | SLC3A1 |
HGNC: | 11025 |
UniProt: | G3V1I5 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
kidney | 2.77e-11 | 26 |
kidney mesenchyme | 2.77e-11 | 26 |
upper urinary tract | 2.77e-11 | 26 |
kidney rudiment | 2.77e-11 | 26 |
kidney field | 2.77e-11 | 26 |
cavitated compound organ | 1.20e-09 | 31 |
urinary system structure | 1.00e-06 | 47 |